1. Elly O. Munde, Prakasha Kempaiah, Angela O. Achieng’, Lily Kisia, Evans Raballah, Samuel B. Anyona, Collins Ouma and Douglas J. Perkins Association between genotype combinations of the Nuclear factor B1 (NFKB1) and nuclear factor inhibitor alpha (NFĸBIA) and severe malaria anemia in from western Kenya. The 7thMIM Conference on Malaria 2018 at Centre International de Conferences Abdou Diouf (CICAD), Dakar, Senegal (Oral presentation)
  2. Elly O. Munde, Prakasha Kempaiah, Angela O. Achieng’, Lily Kisia, Evans Raballah, Samuel B. Anyona, Collins Ouma and Douglas J. Perkins. Variations in the CD40 promoter are associated with susceptibility to falciparum-induced severe malaria anemia in Kenyan children.  ASTMH 2017 Poster #1657
  3. Elly O. Munde,Prakasha Kempaiah , Angela L. Omondi, Lily Kisia, Evans O. Raballah, Samuel B. Anyona, Collins Ouma and Douglas J Perkins.. NFκB1 and NFκBIA promoter polymorphisms and susceptibility to pediatric severe malaria anemi (ASTMH Oral presentation 2016). 
  4. Elly O. Munde, Prakasha Kempaiah , Angela L. Omondi, Lily Kisia, Evans O. Raballah, Samuel B. Anyona, Collins Ouma and Douglas J Perkins. Haplotype within NFĸB1 promoter is associated with risk of severe malaria anaemia and changes in levels of circulating IL-17 in children with falciparum malaria.  ASTMH 2015 Poster #1621
  5. Evans Raballah, Elly O. Munde, Prakasha Kempaiah, Samuel B. Anyona, Zachary Karim, Mark Webale, George Orinda, Michael F. Otieno, Frank Onyambu, James B. Hittner, Lilian Ogonda, Douglas J. Perkins and John M. Ong’echa: Circulating immunoglobulin (Ig)-G against MSP1-42and PfEMP-1 are not associated with pediatric malaria severity in western Kenya: ASTMH Nov 2014, Abstract #1553 Nov 2014.
  6. B Anyona, K Ha, P Kempaiah,Z Karim,E Raballah, E Munde, F. Onyambu, JM Ong’echa, and DJ Perkins: Association between Inducible Heme Oxygenase (HMOX)-1 Gene Variants and Severe Malarial Anemia among Children Resident in a Plasmodium falciparum Holoendemic Region of Western Kenya. ASTMH Nov 2014, Abstract #968 Nov 2014.
  7. Elly O. Munde, Winnie A. Okeyo, Samwel B. Anyona, Evans Raballah, Wilson Okumu, Douglas J. Perkins, John Vulule, Lilian Ogonda and Collins Ouma: Fc gamma receptor IIIA polymorphisms and differential anti-malarial IgG response in children with severe malaria anemia:1st Africa International Biotechnology & Biomedical Conference and the 8th International Workshop on Approaches to Single-Cell Analysis Nairobi, Kenya 4th September 2014 Abstract # WPX 5
  8. Elly O. Munde, Evans Rabala, Winnie A. Okeyo, Caroline A. Owaade, Samwel B. Anyona, Wilson Okumu, John M. Vulule, John m. Ongecha, Douglas J. Perkins and Collins Ouma. A variant within the CD14 Promoter (-159C/T) is associated with increased susceptibility to pediatric malarial anemia in a holoendemic Plasmodium falciparum transmission area. The 6thMIM Pan-African Malaria Conference, October 2013 Durban, South Africa.
  9. Winnie A. Okeyo,Elly O. Munde, Evans Rabala, Samwel B. Anyona, Wilson Okumu, John M. Vulule, John m. Ongecha, Douglas J. Perkins and Collins Ouma. Polymorphisms within the Interleukin-23 receptor (IL-23R) exon are associated with susceptibility to pediatric severe malaria anemia in western Kenya.  6th MIM Pan-African Malaria Conference, October 2013.
  10. Wilson Okumu, Winnie A. Okeyo, Elly O. Munde, Evans Raballah, Samwel B. Anyona and Collins Ouma. Evaluation of saliva derived genomic DNA using OMNIgene®.DISCOVER in detection of malaria and human single nucleotide polymorphisms genotyping.6th MIM Pan-African Malaria Conference, October 2013.
  11. Elly O. Munde, Winnie A. Okeyo, Sussy K. Gumo, Lilian Ogonda, Wilson Okumu, George Orinda and Collins Ouma. Variants within the FcγRIIIA-176A/C and Tolllike receptor (TLR)-9 (-1237T/C) gene promoter is associated with increased susceptibility to pediatric severe malarial anemia and circulating interferon gamma. ASTMH Nov 2012, Abstract #1183.
  12. Winnie A. Okeyo, Elly O. Munde, Carren A. Watsiera, Wilson Okumu, George Orinda and Collins Ouma. Variation within the Interleukin-13 (-7402T/G and -4729G/A) is associated with susceptibility to pediatric severe malaria anemia and functional changes in circulating IL-13. ASTMH Nov 2012, Abstract #1184

PATENTS / INNOVATIONS

  1. N. Wangai and CWA Archdiocese of Nairobi. Features of the Headscarf design for which novelty is claimed are in the pattern and ornamentation. Industrial Design number 941 of application number KE/D/2017/ 1687. Certified 24th August 2017.
  2. N. Wangai and CWA Archdiocese of Nairobi. Features of the Badge design for which novelty is claimed are in the pattern and ornamentation. Industrial Design number 942 of application number KE/D/2017/ 1688. Certified 24th August 2017.
  3. N. Wangai and CWA Archdiocese of Nairobi. Features of the Lesso design for which novelty is claimed are in the pattern and ornamentation. Industrial Design number 943 of application number KE/D/2017/ 1689. Certified 24th August 2017.
  4. N. Wangai and CWA Archdiocese of Nairobi. Features of the Uniform Material design for which novelty is claimed are in the pattern and ornamentation. Industrial Design number 944 of application number KE/D/2017/ 1690. Certified 24th August 2017.
  5. L.N. Wangai, B.K.Ndura, G.K.Muriira, R.H.N.Karanja, P.N. Karanja, M.K. Gitau.Hyssop (Capparis tomentosa) medicinal product used in management of chronic diseases. – KE / P / 2013 / 001885. Patent Number KE 691. Certified  11TH June, 2015